Nutrien (NYSE:NTR – Get Free Report) had its price objective increased by equities researchers at Morgan Stanley from $77.00 to $93.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s price objective would indicate a potential upside of 27.78% from the company’s current price.
A number of other research firms have also weighed in on NTR. TD Securities boosted their target price on Nutrien from $80.00 to $81.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Canadian Imperial Bank of Commerce boosted their target price on Nutrien from $81.00 to $90.00 and gave the stock an “outperformer” rating in a report on Tuesday, March 17th. Wells Fargo & Company upgraded Nutrien from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $77.00 to $100.00 in a research note on Friday, March 13th. UBS Group downgraded Nutrien from a “neutral” rating to a “sell” rating and boosted their price target for the company from $63.00 to $67.00 in a research note on Thursday, March 26th. Finally, BMO Capital Markets boosted their price target on Nutrien from $85.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, March 18th. Eleven research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Nutrien has an average rating of “Hold” and a consensus price target of $78.50.
Read Our Latest Stock Report on NTR
Nutrien Trading Down 2.8%
Nutrien (NYSE:NTR – Get Free Report) last released its earnings results on Wednesday, February 18th. The company reported $0.83 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.04). The firm had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The company’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.31 EPS. As a group, analysts anticipate that Nutrien will post 3.72 earnings per share for the current fiscal year.
Institutional Trading of Nutrien
Several institutional investors and hedge funds have recently modified their holdings of the business. Montag A & Associates Inc. raised its position in Nutrien by 310.7% in the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after purchasing an additional 320 shares during the last quarter. Sfam LLC bought a new position in Nutrien in the fourth quarter valued at about $37,000. Root Financial Partners LLC bought a new position in Nutrien in the third quarter valued at about $37,000. Eastern Bank raised its position in Nutrien by 133.0% in the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after purchasing an additional 399 shares during the last quarter. Finally, Harbour Investments Inc. raised its position in Nutrien by 97.2% in the fourth quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock valued at $43,000 after purchasing an additional 347 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors.
About Nutrien
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Featured Stories
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
